Date: 2012-10-01
Type of information: Fundraising
Company: Antabio (France)
Investors: more than 200 small investors
Amount:
Funding type: crowdfunding
Planned used: This seed funding round allows the company to finance a key step in the validation of its drug candidate molecules.
Others: Antabio, a biopharmaceutical antibacterial drug discovery company, and WiSEED, the French crowdfunding platform dedicated to innovative & technologic startups, have announced the successful completion of their seed round of financing with a profitable exit of the initial small investors, a world premiere in the field of crowdfunding applied to biotech start-up financing.
Therapeutic area: Infectious diseases
